Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 3 years ago
Share
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer
27 patients around the world
Available in
Brazil
Instituto do Cancer do Estado de São Paulo
1
Research sites
27
Patients around the world
This study is for people with
Gastric cancer
Requirements for the patient
To 75 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
Sites
Instituto do Cancer do Estado de Sao Paulo
Recruiting
View site
Av. Dr. Arnaldo, 251 - Cerqueira César, São Paulo - SP, 01246-000
Instituto do Cancer do Estado de Sao Paulo
Recruiting
View site
Av. Dr. Arnaldo, 251 - Cerqueira César, São Paulo - SP, 01246-000
See details
Contact us
Contact us
Study
FOLFIRINOX
Sponsor
Instituto do Cancer do Estado de São Paulo
Study type
Interventional
Conditions
Gastric cancer
Requirements
To 75 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT03825861
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent